As of 2026-03-29, Skyrizi（利生奇珠单抗）'s data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 1.2 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, Skyrizi（利生奇珠单抗）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
Skyrizi（利生奇珠单抗）'s Mention Rate is 0.00%, lower than 0.6% of competitors
Skyrizi（利生奇珠单抗）'s First Mention is 0.00%, lower than 0.9% of competitors
Skyrizi（利生奇珠单抗）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
Skyrizi（利生奇珠单抗）'s Positive Rate is 0.00%, lower than 8.9% of competitors
Skyrizi（利生奇珠单抗）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| ZZepbound | 8.16% | 0% | 0% | 8.16% | 0% | View Details |
| WWegovy | 2.04% | 0% | 0% | 2.04% | 0% | View Details |
| 修修美乐（Humira） | 2.04% | 0% | 0% | 2.04% | 0% | View Details |
| 司司美格鲁肽系列 | 0% | 0% | 0% | 0% | 0% | View Details |
| OOzempic | 0% | 0% | 0% | 0% | 0% | View Details |
| KKeytruda（K药） | 0% | 0% | 0% | 0% | 0% | View Details |
| SSkyrizi（利生奇珠单抗） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
